Immunotherapy and gene therapy

Seminars in Urologic Oncology

Volumn 14, Issue 4, 1996, Pages 237-243

  Gitlitz, B J ^a   Belldegrun, A ^a   Figlin, R A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

interferon alfa; interleukin 2; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; CD8 ANTIGEN; INTERLEUKIN 2; ISOTRETINOIN; TUMOR VACCINE;

ADOPTIVE IMMUNOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; DOSE RESPONSE; GENE THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; LYMPHOKINE ACTIVATED KILLER CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR ASSOCIATED LEUKOCYTE;

CARCINOMA, RENAL CELL; GENE THERAPY; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS; PROGNOSIS;

EID: 0029955481     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)